These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 29926931)
1. The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis. Xiao JF; Sun QY; Ding LW; Chien W; Liu XY; Mayakonda A; Jiang YY; Loh XY; Ran XB; Doan NB; Castor B; Chia D; Said JW; Tan KT; Yang H; Fu XY; Lin DC; Koeffler HP J Pathol; 2018 Sep; 246(1):89-102. PubMed ID: 29926931 [TBL] [Abstract][Full Text] [Related]
2. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2. Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785 [TBL] [Abstract][Full Text] [Related]
3. SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression. Shang W; Wang Y; Liang X; Li T; Shao W; Liu F; Cui X; Wang Y; Lv L; Chai L; Qu L; Zheng L; Jia J J Pathol; 2021 Feb; 253(2):148-159. PubMed ID: 33044755 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis. Luo HB; Li B; Yuan WG; Xu CR J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630 [TBL] [Abstract][Full Text] [Related]
5. Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis. Yu L; Ye F; Li YY; Zhan YZ; Liu Y; Yan HM; Fang Y; Xie YW; Zhang FJ; Chen LH; Ding Y; Chen KL Carcinogenesis; 2020 Jul; 41(5):678-688. PubMed ID: 31306481 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation. Wu M; Fan B; Guo Q; Li Y; Chen R; Lv N; Diao Y; Luo Y Biol Res; 2018 Oct; 51(1):39. PubMed ID: 30309377 [TBL] [Abstract][Full Text] [Related]
7. MUC1-C activates BMI1 in human cancer cells. Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710 [TBL] [Abstract][Full Text] [Related]
9. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Mawson A; Lai A; Carroll JS; Sergio CM; Mitchell CJ; Sarcevic B Mol Cell Endocrinol; 2005 Jan; 229(1-2):161-73. PubMed ID: 15607540 [TBL] [Abstract][Full Text] [Related]
10. GNA13 suppresses proliferation of ER+ breast cancer cells via ERα dependent upregulation of the MYC oncogene. Subramanyan LV; Rasheed SAK; Wang L; Ghosh S; Ong MSN; Lakshmanan M; Wang M; Casey PJ Breast Cancer Res; 2024 Jul; 26(1):113. PubMed ID: 38965558 [TBL] [Abstract][Full Text] [Related]
11. A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway. Cho JH; Dimri M; Dimri GP J Biol Chem; 2013 Feb; 288(5):3406-18. PubMed ID: 23239878 [TBL] [Abstract][Full Text] [Related]
12. AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions. Guo J; Dai X; Laurent B; Zheng N; Gan W; Zhang J; Guo A; Yuan M; Liu P; Asara JM; Toker A; Shi Y; Pandolfi PP; Wei W Nat Cell Biol; 2019 Feb; 21(2):226-237. PubMed ID: 30692625 [TBL] [Abstract][Full Text] [Related]
13. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells. Gergely JE; Dorsey AE; Dimri GP; Dimri M Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145 [TBL] [Abstract][Full Text] [Related]
14. Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis. Regina C; Compagnone M; Peschiaroli A; Lena A; Annicchiarico-Petruzzelli M; Piro MC; Melino G; Candi E Oncotarget; 2016 May; 7(20):28836-48. PubMed ID: 26840455 [TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c-MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer. Xie J; Ni J; Shi H; Wang K; Ma X; Li W; Peng B Cancer Med; 2023 Mar; 12(5):5718-5735. PubMed ID: 36208024 [TBL] [Abstract][Full Text] [Related]
16. Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma. Wang HB; Liu GH; Zhang H; Xing S; Hu LJ; Zhao WF; Xie B; Li MZ; Zeng BH; Li Y; Zeng MS FEBS J; 2013 Jun; 280(12):2929-44. PubMed ID: 23601184 [TBL] [Abstract][Full Text] [Related]
18. SETDB1 regulates SMAD7 expression for breast cancer metastasis. Ryu TY; Kim K; Kim SK; Oh JH; Min JK; Jung CR; Son MY; Kim DS; Cho HS BMB Rep; 2019 Feb; 52(2):139-144. PubMed ID: 30545440 [TBL] [Abstract][Full Text] [Related]
19. Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer. Ojo D; Lin X; Wu Y; Cockburn J; Bane A; Tang D Cancer Lett; 2018 Jul; 426():4-13. PubMed ID: 29626519 [TBL] [Abstract][Full Text] [Related]
20. Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells. Kim D; Hong A; Park HI; Shin WH; Yoo L; Jeon SJ; Chung KC J Cell Physiol; 2017 Dec; 232(12):3664-3676. PubMed ID: 28160502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]